000			02999nam a22003017a 4500
001			CRECU/2251 19.04.2022
003			OSt
005			20240305193955.0
008			221212b |||||||| |||| 00| 0 eng d
028			_bPhone: +255 28 298 3384
028			_b Fax: +255 28 298 3386
028			_b Email: vc@bugando.ac.tz
028			_b Website: www.bugando.ac.tz
040			_bEnglish _cDLC
041			_aEnglish
041			_aKiswahili
100			_aHarrison Benard _dCUHAS/BP/3000776/T/18 _947258 _eUndergraduate Ethical Clearance Certificate No. 2251/2022
210			_2Research Report Submitted in Partial Fulfilment for the Award of Bachelor of Pharmacy Degree of Catholic University of Health and Allied Sciences. _aABBREVIATIONS BMC Bugando Medical Centre CUHAS Catholic University of Health and Allied Sciences IDF International Diabetes Federation WHO World Health Organisation
222			_aOPERATIONAL DEFINITIONS _bPolypharmacy Refers to the concurrent use of medications five or more medications.
245			_aPolypharmacy among patients with type 2 diabetes mellitus at Bugando Medical Centre, Mwanza Tanzania
260			_aMwanza, Tanzania: _b Catholic University of Health and Allied Sciences [CUHAS – Bugando] _c07.09.2022
300			_ax; 21 Pages
300			_aIncludes References and Appendices
520			_aABSTRACT: Background: Type 2 diabetes mellitus is the one of the common chronic conditions which is usually associates with other comorbidities, being highly prevalent to adults’ patients with diabetes are likely to use more than five medications, when treating diabetes conditions and other underlying disease such as cardiovascular disease, chronic kidney disease and neuropathic disease. This study aims to identify prevalence and risk factors of polypharmacy among patients with type 2 diabetes mellitus. Methodology: Hospital based retrospective study which was conducted among outpatient adults with type 2 diabetes mellitus who have visited BMC from January 2021 to December 2021, convenience sampling procedure was used to collect data from electronic health management system. Conclusion / discussion: There is high prevalence of polypharmacy among patients with diabetes. Risk factors being age and co-existing conditions such as cardiovascular diseases. Results: Of the 261 patients, 157 (60.1%) were using more than five medications which was more likely to older patients above 60 years than those below. Polypharmacy was highly reported to patient with at least one comorbidity (91.1%) than those with diabetes only (8.9%). Patients with cardiovascular disease had high prevalence (71.3%) and was reported at least on patient with respiratory disorders, chronic kidney disease, metabolic disorder and other disease. Female patients had high prevalence of polypharmacy (52.9%) than male patients (47.1%).
600			_xInternal Medicine _915587
700			_aIgembe Nkandala _922894
942			_2ddc _cCR
999			_c22626 _d22626